Detalhe da pesquisa
1.
Liraglutide relieves cardiac dilated function than DPP-4 inhibitors.
Eur J Clin Invest
; 48(10): e13007, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30054920
2.
The Vasopressin 2 Receptor Antagonist Tolvaptan Improves Nutrition and Inflammatory States in Peritoneal Dialysis Patients with Diabetes Mellitus.
Adv Perit Dial
; 31: 30-3, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26714385
3.
Pharmacokinetics and metabolism of [14C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans.
Xenobiotica
; 43(5): 432-42, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23075005
4.
When should icodextrin be started to improve atherosclerosis in peritoneal dialysis patients?
Adv Perit Dial
; 29: 4-8, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24344482
5.
Icodextrin eliminates phosphate and ameliorates cardiac hypertrophy and valvular calcification in patients with end-stage renal disease and diabetes mellitus undergoing peritoneal dialysis.
Adv Perit Dial
; 29: 9-13, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24344483
6.
Pharmacokinetic disposition of anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in rats and dogs.
Eur J Drug Metab Pharmacokinet
; 38(2): 87-96, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23436178
7.
Impact of glucagon like peptide-1 receptor agonist and sodium glucose cotransporter 2 inhibitors on type 2 diabetes patients with renal impairment.
Diab Vasc Dis Res
; 17(6): 1479164120971220, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33371732
8.
Quality of Life and Emotional Distress in Peritoneal Dialysis and Hemodialysis Patients.
Ther Apher Dial
; 24(4): 366-372, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31671240
9.
Dipeptidyl peptidase 4 inhibitor anagliptin ameliorates hypercholesterolemia in hypercholesterolemic mice through inhibition of intestinal cholesterol transport.
J Diabetes Investig
; 9(6): 1261-1269, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29754453
10.
Favorable changes in lipid metabolism and cardiovascular parameters after icodextrin use in peritoneal dialysis patients.
Adv Perit Dial
; 23: 58-61, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17886604
11.
Longitudinal changes in parameters of cardiovascular function in patients treated for 8 years with hemodialysis or peritoneal dialysis.
Adv Perit Dial
; 23: 62-5, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17886605
12.
Impact of dialysis modality on ultrasonographic cardiovascular parameters in elderly patients.
Adv Perit Dial
; 23: 94-7, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17886611
13.
Long Term Effects of Liraglutide in Japanese Patients with type 2 Diabetes Among the Subgroups with Different Renal Functions: Results of 2-Year Prospective Study.
Drug Res (Stuttg)
; 67(11): 640-646, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28738426
14.
A Pilot Study Examining the Effects of Tolvaptan on Residual Renal Function in Peritoneal Dialysis for Diabetics.
Perit Dial Int
; 35(5): 552-8, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25082843
15.
Liraglutide Improves Glycemic and Blood Pressure Control and Ameliorates Progression of Left Ventricular Hypertrophy in Patients with Type 2 Diabetes Mellitus on Peritoneal Dialysis.
Ther Apher Dial
; 19(6): 598-605, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26556397
16.
The alpha-glucosidase inhibitor miglitol affects bile acid metabolism and ameliorates obesity and insulin resistance in diabetic mice.
Metabolism
; 62(5): 734-42, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23194643
17.
Association between DNA methylation in the miR-328 5'-flanking region and inter-individual differences in miR-328 and BCRP expression in human placenta.
PLoS One
; 8(8): e72906, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23991164